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Summary - In  the  karyotypes  of the  bat  species  Molossus  ater and M  molossus,
spontaneous and bromodeoxyuridine (BrdU)- or aphidicolin (APC)-sensitive fragile sites
were located. Four chromosome  regions harbored APC-sensitive fragile sites: lq9 and 8q4
in both M ater  and M  molossus, 3q3  in M ater, and lp7  in M  molossus. The  fragile sites in
lq9 and 8q4 were also observed without induction in M  molossus. BrdU-sensitive fragile
sites were not detected.  Despite observations in several other species,  the fragile  sites
detected in Molossus  are not coincident with the breakpoints involved in the chromosome
rearrangements occurring in the evolution of 7 species of the Molossidae family.
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Résumé - Identification  de sites  chromosomiques fragiles  communs à  2  espèces
de chauve-souris.  L’analyse  de  la  fragilité  chromosomique spontanée  ou  induite par
bromodéoxyuridine (BrdU) et aphidicholine (APC), réalisée sur le caryotype de  2 espèces
de chauve-souris, Molossus  ater et M  molossus, a  permis d’identifier  4 sites fragiles induits
par APC:  1 q9 et 8q4 chez  M ater et M  molossus, 3q3 chez  M ater et 1 p7 chez M  molossus.
Les sites fragiles en 1 q9  et 8q4 ont aussi été observés chez M  molossus sans induction.
Les sites fragiles  repérés dans ces  espèces ne coincident pas avec les points de cassure
impliqués dans les réarrangements chromosomiques qui ont eu lieu au cours de l’évolution
de 7  espèces de la famille des Molossidae.
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induction par aphidicholineINTRODUCTION
Fragile  sites  are  specific  points  on chromosomes which are  expressed  as  non-
randomly distributed gaps and breaks when chromosomes are exposed to specific
agents or  culture  conditions  (Berger  et  al,  1985).  The induction of fragile  site
expression is  generally related to imbalance of deoxyribonucleotide pools during
G 1   and S  phases  following thymidylate stress  (Yan  et  al,  1988)  or  treatment
with the thymidine analogue bromodeoxyuridine (BrdU) (Sutherland et al,  1985).
Expression of fragile sites can also be induced at high frequencies by inhibitors
of DNA  semiconservative and repair synthesis, including aphidicolin (Glover et al,
1984), arabinofuranosyl cytosine, and arabinofuranosyl adenosine (Leonard et  al,
1988).
Although the biological significance of fragile sites remains unclear, they have
attracted  attention  since the  rare  fragile site in Xq27.3  and  a  type  of  X-linked  mental
retardation in humans  were associated (Sutherland and  Hecht, 1985). Furthermore,
several findings have correlated fragile sites with chromosomal rearrangements in
cancer (Le Beau, 1986; De  Braekeleer, 1987; Mir6 et al,  1987), infertility in humans
(Schlegelberger  et  al,  1989),  breakpoints involved  in  chromosomal evolution  of
primates (Mir6 et al, 1987), and  preservation  of syntenic groups  in mammals  (Djalali
et al,  1987; Threadgill and Womack, 1989).
More than 100 fragile  sites  have been identified  in human chromosomes,  all
classified by their band location, gene symbol, population frequencies, and mode
of induction (Mir6 et al,  1987; Hecht et al,  1990). BrdU-sensitive fragile sites have
also been  described in Chinese hamsters (Hsu and Sommers, 1961; Lin et al,  1984),
cactus mice (Schneider et al,  1980), cattle (Di Berardino et al,  1983), and reindeer
(Gripenberg et al,  1991). BrdU- and/or folate-sensitive fragile sites were recently
reported in the horse karyotype (R o nne,  1992). Aphidicolin (APC)-sensitive fragile
sites have been detected in the chromosomes of mice (Djalali  et  al,  1987; Elder
and Robinson, 1989; McAllister and Greenbaum, 1991), rats (Robinson and Elder,
1987), dogs (Wurster-Hill et  al,  1988; Stone et  al,  1991a, 1991b), pigs (Riggs and
Chrisman, 1991), and rabbits (Poulsen and Ronne, 1991). Folate-sensitive fragile
sites were detected in the Persian vole (Djalali et al,  1985), the mouse (Sanz et al,
1986), cattle (Uchida et al,  1986), and in the Indian mole  rat (Tewari et al,  1987).
To determine the potential phylogenetic implications of chromosomal fragility
in the evolution of bats, common BrdU- and APC-sensitive fragile  sites  in the
karyotype of 2  species  of the  family Molossidae  (Chiroptera,  Mammalia) were
examined.
MATERIALS AND  METHODS
Primary cultures of fibroblasts were derived from explants of ears from a total of
9 animals of  the species Molossus ater and  8 from Molossus molossus. The  cultures
were established and maintained in Eagles’ minimum essential medium (MEM)
supplemented with 20%  fetal calf serum, L-glutamine, penicillin and  streptomycin.
BrdU (20 gM) and APC  (0.02 gM) were added to cultures 26 h before harvest. In
order to avoid the photolysis of DNA  containing BrdU, the culture flasks were kept
in the dark  and  covered  with  aluminium  foil after BrdU  was  added. Each  experimentwas  performed with concurrent control cultures. Colchicine (4 x 10- 4 M)  was added
to the cultures 30 min  before harvest. Cells were  exposed  to 0.8% sodium  citrate for
30 min, fixed in methanol/acetic acid 3:1, dropped onto wet slides, and air-dried.
Slides were homogeneously stained with 2% Giemsa and around 100 metaphases
from coded  slides of treated and untreated cultures of each animal were scored for
breaks, gaps, and rearrangements. After identification of the lesion, the slides were
destained and GTG  banding (G-band  after trypsin and  giemsa  treatment) was  used
to identify the exact localization of the aberrations.
To determine the presence of a fragile site,  2 criteria were considered:  (i)  the
occurrence of at least 2%  lesions at a given chromosome region in cells submitted
to a certain culture condition in at least 2 animals of  the same  species; and  (ii) the
homozygous expression of a lesion. A  chi-squared analysis of the distribution of
anomalies was performed to determined whether their  frequencies were equally
distributed in treatments and controls.
RESULTS
The  diploid number  of  chromosomes  in M ater  and M  molossus  is 2n =  48 and  their
karyotypes have similar morphology and G-band pattern (fig  1). The frequencies
of spontaneous, BrdU- and APC-induced lesions in bat chromosomes are given in
table I.  These lesions manifested themselves as either nonstaining gaps, chromatid
or chromosome  breaks, or deletions.
The number  of aberrations in BrdU-treated and untreated (control) cultures of
M ater and M  molossus was low, but BrdU-treated cells were significantly more
damaged than controls (x 2  =  8.9;  1  df; P  <  0.05). Only 3.6% of the cells in the
BrdU-treated  cultures and  0.6%  of  cells in the control cultures showed chromosome
lesions in M ater, with  a  total of  20 and  3 events, respectively. In M  molossus  3.8%  of
the cells in the control culture and 4.8% of BrdU-treated  cells showed chromosome
lesions, with a total of 18 and 19 events, respectively. The location of these gapsand breaks was variable but they occurred in the euchromatic chromosome arms.
Chromatid gap was the most frequent event.
Four chromosome  bands  exhibited lesions in at least 2%  of  the  cells in the BrdU-
treated cultures: lq5 and lq9 in M ater; 1q13 and 8q4 in M  molossus. M  molossus
also exhibited lesions in  lp7 in the control cultures.  Nevertheless, none of thesebands  were  considered  to harbor  fragile sites since the  aberrations  were  not observed
in the homozygous conditions or in more than one animal of the same  species.
The APC  treatment was more  effective in the induction of chromosomal aberra-
tions than  BrdU: 9.2%  of  the  cells presented  a  total of  50  anomalies  in M ater; 11.5%
of the cells exhibited a total of 75 aberrations in M  molossus (table I). More than
one  lesion or the homozygous  expression of  a  given aberration occurred  in a number
of cells.  In these tests, the most frequent type of aberration was the chromosome
gap. The  chi-squared analysis detected  significantly more  damaged  chromosomes  in
the APC-treated than in the control cultures (x 2  
=  20.0; 1 df; P  <  0.001).
Fourteen regions in the euchromatic arms in which such lesions occurred were
identified in at least 2%  of the cells:  lp7,  lq5, lq9, 1q13, 3q3, 4q3-4, 5q8, 7q3-4,
8q4, 8q5-6, lOq3-4, 20q2 and  Xq4-6  in the APC-treated  cultures and 1q13-15 in the
control cultures (fig 2A). However, only 4 of these 14 regions fulfilled the criteria
to be qualified as harboring fragile sites (fig 2B): lq9 and 8q4 in both M ater  and
M  molossus, lp7 in M  Molossus, and 3q3 in M ater. The fragile sites in lq9 and
8q4 were also observed without induction in M  molossus. The highest expression
rate (8%) was achieved by 8q4. Furthermore, an interindividual variation in the
frequencies of expression of the fragile sites was observed in all of the 4 bands, as
well as an interspecific variation observed in lq9 and 8q4.
It  is important to emphasize that the 5 bands referred to above as presenting
lesions in the test with BrdU (lp7,  lq5, lq9, 1q13 and 8q4) are included in the
14 identified in APC  treatment and  3 (1p7, lq9, and  8q4) are included in the 4 that
harbored fragile sites.
DISCUSSION
The mechanisms of expression of the BrdU-sensitive fragile  site  are not totally
understood. The  chronology of the events after exposure to this chemical indicates
that it acts during the late S-phase and  affects late replicating regions (Sutherland
et al,  1984, 1985). An  increased frequency of gaps and breaks in the chromosomes
of M ater and M  molossus was observed when  the thymidine analogue BrdU was
incorporated. However, the frequencies and conditions in which these alterations
were expressed did not fit  the criteria for qualification of the affected region as
harboring fragile sites. These findings may  be related to the period of exposure to
BrdU  (26 h). Although  exposure  to BrdU  for 18-26 h  has been  used  for experiments
with human  lymphocytes  and  several mammalian  fibroblasts (Schneider et al, 1980;
Lin et al, 1984; Fundia  and  Larripa, 1989), the  highest expression  of  common  BrdU-
sensitive fragile sites in human  lymphocytes was achieved after 4-12 h  of treatment
(Sutherland et  al,  1984,  1985). Furthermore, fragile  sites have been identified in
both  lymphocyte  and  fibroblast cultures, but  the  cells in the  latter appear  refractory
to their expression (Robinson and Elder, 1987). Hence, the lower frequency in the
expression  of  the  fragile sites in bat  fibroblasts may  be  due  to the  specific refractivity
of this cell type as well as to a susceptibility of lymphocytes.
The  chromosome  aberrations observed in BrdU-treated  cells in the present study
consisted mainly of chromatid gaps, which is  similar to the findings of Lin et  al
(1984) in the hamster genome. Reviewing the genetic toxicology of BrdU, Morris(1991) also confirmed that the aberrations induced by  this chemical were primarily
of the chromatid type and included gaps, breaks and interchanges.
APC, a diterpenoid mycotoxin that inhibits alpha DNA  polymerase associated
with DNA  replication, induces gaps and breaks at common  fragile sites in human
chromosomes (Glover et al,  1984), either as chromosome or chromatid aberrations
(Murano et  al,  1989). The most frequent type of aberration exhibited by APC-
treated cells in this study was the chromosome gap. The results may reflect the
number  of cycles a cell had completed after the introduction of APC  into cultures,
and/or even the efficiency of the repair mechanisms.
It is interesting to note that the fragility observed in the Xq4-6 was displayed by
only 1 animal  of  the species M ater, and  so  this region was  not qualified as harboring
a fragile site in this work. Corresponding X-fragility has been observed in several
distantly related mammalian  species including humans, horses, rats, rabbits, pigs,
dogs, and cattle (R o nne  et al,  1993). The  putative Xq4-6 fragility observed in thisstudy may  then correspond to the Xq22 fragility observed in humans, horses, and
rats (R o nne  et al,  1993).
Since the species present complete homology in their karyotypes, the interspe-
cific variation was surprising. Conservation of 5-azacytidine-sensitive fragile sites
was described in primates (Schmid et al,  1985), as well as fragility in bands shared
by horses and humans (Ronne, 1992). Beyond  the interspecific and interindividual
variations observed  in the number  of  regions harboring  fragile sites, individual vari-
ation in the frequency of cells expressing the fragile sites was also observed among
positive specimens, as previously reported, for instance, in rabbits (Poulsen and
Ronne, 1991) and humans (Craig-Holmes et al,  1987). Variation in the molecular
nature of the fragile sites could explain variation in expressivity, as exemplified by
the human  fragile site in Xq27.3. A  highly polymorphic CGG  repeat was  discovered
within the gene FMR-1 mapped  in this region and a somatic mosaicism was well
documented, indicating mitotic instability of alleles (Fu et al,  1991). Large expan-
sions of the repeated region (250-4 000 repeats) are probably more  easily detected
by cytogenetic analysis than small expansions (52-200 repeats).
Despite the observed association between the fragile sites and the breakpoints
involved in chromosomal rearrangements in several animal species  (Djalali  et  al,
1985; Mir6 et  al,  1987; Riggs and Chrisman, 1991), our results did not show any
coincidence between the detected bands harboring fragile sites  in the species of
Molossus and the breakpoints involved in chromosomal rearrangements occurring
in the evolution of 7 species  of the family Molossidae (Morielle-Versute,  1992).
However a more detailed study is  necessary to verify the complete relationship
between these 2 phenomena  in bats.
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